Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19215716 | 0.90 | TSHR (0.38) | TSHRHSD17B10LMNA | |
| SCHEMBL4942699 | 0.90 | TSHR (0.38) | TSHRHSD17B10LMNA | |
| SCHEMBL28752174 | 0.87 | SPHK1 (0.45) | LMNASPHK1 | |
| SCHEMBL430876 | 0.78 | TSHR (0.33) | TSHRCHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL2167547 | 0.78 | — | — | |
| SCHEMBL4440508 | 0.78 | — | — | |
| SCHEMBL4945754 | 0.77 | — | — | |
| Ammonia Solution, Strong SCHEMBL241739 | 0.76 | TSHR (0.32) | TSHRCHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL10783170 | 0.74 | CTSK (0.48) | SLC6A3HDAC1HDAC2 | |
| Ethylene Glycol SCHEMBL22581580 | 0.74 | TSHR (0.39) | TSHRHSD17B10LMNACHRM1AKR1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1939165-B1 | POLYVINYL ETHER COMPOUND | IDEMITSU KOSAN CO (JP) | 2012-06-13 | — | — | EP | disclosed |
| EP-1939165-A1 | POLYVINYL ETHER COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2008-07-02 | — | — | EP | disclosed |
| US-20080108850-A1 | Addition-condensation copolymers containing polyoxyethylene glycol; high viscosity; used as lubricating oil for compression refrigerator | IDEMITSU KOSAN CO., LTD. (JP) | 2008-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080108850-A1 | Addition-condensation copolymers containing polyoxyethylene glycol; high viscosity; used as lubricating oil for compression refrigerator | CENPE, INCENP, CETP | TSHR 4803/4885HSD17B10 896/4885LMNA 114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.